Free Newsletter
Chickenpox vax program a success
Reports of chickenpox have drastically declined as a result of the national vaccination program implemented in the 1990s. In a study published in the journal Pediatrics today, CDC researchers report that the between 1995 and 2005, instances of varicella infections were cut by 90 percent. Chickenpox-related hospitalizations and deaths also fell by 75 percent and 74 percent, respectively.
But there is still a long way to go, according to Mark Slifka, associate scientist at the Vaccine and Gene Therapy Institute at the Oregon Health and Science University. Experts worry about parents who skip their children's vaccines because they believe the virus is harmless. Many are unaware that patients successfully treated for varicella after infection can develop shingles years later.
"Unfortunately, it is unlikely that we will get rid of chickenpox in our lifetime," Slifka, told ABCNews. "Since it can hide in otherwise healthy people for so long before 'jumping out' as infectious virus, it will be nearly impossible to completely eradicate it--at least with the current vaccines that we have available at this time."
- check out the abcNews.com article
Related Articles:
Many infants don't get vaccinations on time
Pediatricians get tough with vaccine doubters
Merck vaccine effective in preventing shingles
Epiphany inks deal for shingles drug
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




